Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia

The FDA just approved Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia.

This is the first antibiotic to be approved for this use.

Strep pneumoniae is the most common cause of community-acquired pneumonia. It used to be very sensitive to penicillin...but now resistance is growing.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote